Perspective Therapeutics
CATX
112 hedge funds and large institutions have $96.4M invested in Perspective Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 36 closing their positions.
318% more call options, than puts
Call options by funds: $92K | Put options by funds: $22K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8.77% less ownership
Funds ownership: 69.91% → 61.14% (-8.8%)
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
17% less funds holding
Funds holding: 135 → 112 (-23)
36% less capital invested
Capital invested by funds: $151M → $96.4M (-$54.3M)
64% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vestor Capital
Chicago,
Illinois
|
+$2.93M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$2.77M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$1.56M |
| 4 |
Morgan Stanley
New York
|
+$1.25M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$985K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$3.8M |
| 2 |
Millennium Management
New York
|
-$3.56M |
| 3 |
Goldman Sachs
New York
|
-$1.8M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.49M |
| 5 |
Walleye Capital
New York
|
-$1.31M |
CATX Hedge Fund Activity: Q1 2025 in Review
112 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2025, worth a combined $96.4M — down 36% from $151M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of CATX and 13 opened new positions — a net loss of 23 holders — while 39 trimmed existing stakes and 35 added.
The largest buyer was Vestor Capital, opening a new position worth an estimated $2.93M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $3.8M sold.
- 112 institutional investors held Perspective Therapeutics (CATX) as of Q1 2025, down from 135 in Q4 2024.
- Funds reported $96.4M of Perspective Therapeutics stock for Q1 2025, down 36% quarter-over-quarter.
- 13 funds opened new Perspective Therapeutics positions in Q1 2025 and 36 closed out, a net change of -23 holders.
- The largest Perspective Therapeutics buyer in Q1 2025 was Vestor Capital, an estimated $2.93M added.
- The largest Perspective Therapeutics seller in Q1 2025 was Perceptive Advisors, an estimated $3.8M sold.
Based on aggregated 13F filings for Q1 2025.